Inflammatory Bowel Disease (IBD) Clinical Trial
Official title:
The Effect of Methotrexate on Sperm Quality in Men With Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract which includes Crohn's disease (CD) and ulcerative colitis (UC) which peak in incidence (rate or frequency) during the reproductive years. An increasing number of young people will face challenging decisions regarding medical management of this chronic disease during a period of time when they are still completing schooling, establishing their career, and/or are building a family. Treatment options for IBD consist of immunosuppressive therapy, such as immunomodulators (azathioprine and methotrexate). Methotrexate (MTX) is a folic acid antagonist (a substance that interferes with or inhibits the action of another). It is thought that MTX works by decreasing the inflammation in the gastrointestinal tract. MTX has been studied for many years and in used as treatment in not only IBD, but also in conditions such as rheumatoid arthritis and lupus. However, due to concerns about the safety of MTX, particularly in regards to fertility and pregnancy has limited its current use. Participants are invited to take part in this research project to determine whether the treatment of IBD patients with MTX is associated with an increased risk for infertility. Investigators will recruit 75 male IBD patients under MTX treatment for their IBD as well as 75 healthy male controls for a total of 150 patients at the University of Wisconsin Hospital & Clinics.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05428345 -
A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
|
||
| Completed |
NCT02265588 -
Healthy Approach to Physical and Psychological Problems in Youngsters With IBD (HAPPY-IBD).
|
N/A | |
| Completed |
NCT01022749 -
Efficacy Safety Study of Flu Vaccine in Immunodepression Patients
|
Phase 3 | |
| Completed |
NCT02461758 -
Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients
|
Phase 4 | |
| Completed |
NCT01095042 -
Cognition and Emotion in the SII and IBD
|
N/A | |
| Completed |
NCT00542776 -
Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine
|
N/A | |
| Completed |
NCT02778464 -
Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease
|
||
| Completed |
NCT02256605 -
Vitamin D3 Supplementation in Pediatric IBD: Weely vs Daily Dosing Regimens
|
N/A | |
| Recruiting |
NCT05078879 -
Empagliflozin as a Treatment for Severe Congenital Neutropenia Due to G6PC3 Deficiency
|
Phase 1 | |
| Completed |
NCT05596422 -
A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD)
|
||
| Completed |
NCT02355834 -
Faecal Incontinence iNtervention Study
|
N/A | |
| Not yet recruiting |
NCT01852097 -
An Online Intervention to Address Barriers to IBD Medication Adherence
|
N/A | |
| Terminated |
NCT00325078 -
Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
|
Phase 1/Phase 2 | |
| Terminated |
NCT03886753 -
Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products
|
||
| Recruiting |
NCT04345393 -
Translating Scientific Evidence Into Practice Using Digital Medicine and Electronic Patient Reported Outcomes
|
N/A | |
| Completed |
NCT01819766 -
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
|
N/A | |
| Completed |
NCT01560819 -
Gut Microbial Transplantation in Pediatric Inflammatory Bowel Diseases
|
Phase 1 | |
| Completed |
NCT00820365 -
SC12267 (4SC-101) for Treatment of Patients With Inflammatory Bowel Disease
|
Phase 2 | |
| Completed |
NCT02156557 -
Study of KCC Peptide Application in the Colon
|
Phase 1 | |
| Completed |
NCT01364896 -
Anal Human Papillomavirus in Inflammatory Bowel Disease Study
|